Adiponectin inhibits oxidized low density lipoprotein-induced increase in matrix metalloproteinase ۹ expression in vascular smooth muscle cells
Publish place: ARYA Atherosclerosis، Vol: 11، Issue: 3
Publish Year: 1394
نوع سند: مقاله ژورنالی
زبان: English
View: 142
This Paper With 5 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_RYA-11-3_005
تاریخ نمایه سازی: 2 شهریور 1401
Abstract:
BACKGROUND: High expression of matrix metalloproteinase ۹ (MMP۹) during vascular injury and inflammation plays an important role in atherosclerotic plaque formation and rupture. In the process of atherosclerosis, oxidized low-density lipoprotein (oxLDL) upregulates MMP۹ in human aortic vascular smooth muscle cells (HA/VSMCs). Adiponectin is an adipose tissue-derived hormone that has been shown to exert anti-atherogenic and anti-inflammatory effects. The aim of this study was to investigate the effect of adiponectin on MMP۹ expression under pathogenic condition created by oxLDL in HA/VSMCs. METHODS: In this experimental study, HA/VSMC were stimulated with oxLDL alone and in the presence of adiponectin for ۲۴ and ۴۸ h. The expression of MMP۹ gene was determined by real-time polymerase chain reaction method. The protein level of this gene was investigated by western blotting technique. RESULTS: An oxLDL increased MMP۹ expression ۲.۱۶ ± ۰.۲۴- and ۳.۳۲ ± ۰.۲۵-fold after ۲۴ and ۴۸ h, respectively and adiponectin decreased oxLDL-induced MMP۹ expression in a time-dependent manner. CONCLUSION: These results show that adiponectin changes extracellular matrix by reducing MMP۹ mRNA and protein, therefore, may stabilize lesions and reduce atheroma rupture.
Keywords:
Authors
Maryam Saneipour
MSc Student, Clinical Biochemistry Research Center, Shahrekord University of Medical Science, Shahrekord, Iran
Keihan Ghatreh-Samani
Assistant Professor, Clinical Biochemistry Research Center, Shahrekord University of Medical Science, Shahrekord, Iran
Esfandiar Heydarian
Associate Professor, Clinical Biochemistry Research Center, Shahrekord University of Medical Science, Shahrekord, Iran
Effat Farrokhi
PhD Candidate, Cellular and Molecular Research Center, Shahrekord University of Medical Science, Shahrekord, Iran
Narges Abdian
PhD Candidate, Cellular and Molecular Research Center, Shahrekord University of Medical Science, Shahrekord, Iran